CEL-SCI Corporation (CVM) Comparison with companies in other sectors?

CEL-SCI Corporation has a share price of 5.14M. You can analyze CEL-SCI Corporation (CVM) competitors across different market sectors through stock heatmaps.

What are CVM's NET and operating margins?

CEL-SCI Corporation (CVM) operating margin is around 0.00, and net profit margin is approximately 0.00 as of the latest reports.

In what way does CVM's earnings per share (EPS) trend reflect its financial momentum?

CEL-SCI Corporation (CVM) EPS is -12.30 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for CEL-SCI Corporation is -0.31, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for CEL-SCI Corporation?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for CEL-SCI Corporation like P/E which is -14.81, P/B which is 0.04, and PEG which is -1.23. Compare them with sector averages to evaluate if the stock is priced fairly.

CEL-SCI Corporation

CVM•AMEX

Healthcare

Biotechnology

$5.05

$2.25(80.36%)

Fundamental Analysis of CEL-SCI Corporation (CVM)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-12.30

P/E Ratio

-0.31

ROE

-0.01%

Net Margin

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$19.46M

Shares OutstandingTotal number of shares issued

$5.14M

Book Value/ShareNet worth per share

$94.60

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-12.3

Net MarginNet income as percentage of revenue

Operating MarginOperating income as percentage of revenue

ROEReturn on shareholders' equity

-1.00%

ROAReturn on total assets

-0.09%

ROCEReturn on capital employed

-0.12%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.21

Cash/ShareCash and equivalents per share

$22.76

FCF YieldFree cash flow as percentage of market cap

-95.33%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for CVMFinancial Ratios Analysis details for CVM are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for CVMSector Benchmarking details for CVM are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for CEL-SCI Corporation Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of CEL-SCI Corporation. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account CEL-SCI Corporation's unique business strengths and challenges.

Key Financial Metrics for CEL-SCI Corporation

For CEL-SCI Corporation, essential financial indicators include EPS -12.30, PE -0.31, and ROE -0.01. These key ratios reveal insights into CEL-SCI Corporation's profitability, valuation, and operational health. Understanding these metrics enables you to compare CEL-SCI Corporation with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of CEL-SCI Corporation

Metrics like Net Margin - and ROA -0.09% shed light on how well CEL-SCI Corporation is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether CEL-SCI Corporation can sustain its operations and continue growing in the future.

Valuation and Market Position of CEL-SCI Corporation

Using ratios such as P/B Ratio 0.04 and PEG Ratio -1.23, investors can assess whether CEL-SCI Corporation is appropriately valued based on its financials and growth potential. These figures, combined with CEL-SCI Corporation's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for CEL-SCI Corporation

Financial health indicators, such as Debt/Equity Ratio 1.32 and Cash Flow $-0.21, provide a snapshot of CEL-SCI Corporation's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like CEL-SCI Corporation, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for CEL-SCI Corporation

Investing in CEL-SCI Corporation based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at CEL-SCI Corporation focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;